Loghin, C
Growth Outlook and Analyst Views Biocon's vision, as articulated by Tambe, focuses on building a trusted brand through "high-end science and innovation." The company's pipeline is strong, with 20 biosimilar assets across diabetology, oncology, immunology, ophthalmology, and bone health
This article explores what is currently known about combining retatrutide with other substances, outlines the relevant safety considerations, and explains what UK clinical guidance says about combination approaches to weight management
When you feel supported and encouraged, youre more likely to stay consistent
683,684 Advanced imaging techniques, such as high-resolution MRI and positron emission tomography, offer potential for early DN detection and disease progression monitoring